Dr Risch
Industry / private company
Location:
Bern,
Switzerland (CH)
ROR: https://ror.org/030f5x630
Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: A population-based study (2021)
Schaffner A, Risch L, Weber M, Thiel S, Jüngert K, Pichler M, Wohlwend N, et al.
Journal article
Characterization of a pan-immunoglobulin assay quantifying antibodies directed against the receptor binding domain of the sars-cov-2 s1-subunit of the spike protein: A population-based study (2020)
Schaffner A, Risch L, Aeschbacher S, Risch C, Weber MC, Thiel SL, Jüngert K, et al.
Journal article